275 related articles for article (PubMed ID: 15649398)
1. Exocytosis of storage material in a lysosomal disorder.
Klein D; Büssow H; Fewou SN; Gieselmann V
Biochem Biophys Res Commun; 2005 Feb; 327(3):663-7. PubMed ID: 15649398
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology of sulfatide metabolism in metachromatic leukodystrophy].
Wiesmann UN
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):33-47. PubMed ID: 27269
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution.
Wittke D; Hartmann D; Gieselmann V; Lüllmann-Rauch R
Acta Neuropathol; 2004 Oct; 108(4):261-71. PubMed ID: 15322834
[TBL] [Abstract][Full Text] [Related]
4. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
[TBL] [Abstract][Full Text] [Related]
5. Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells.
Klein D; Yaghootfam A; Matzner U; Koch B; Braulke T; Gieselmann V
Biol Chem; 2009 Jan; 390(1):41-8. PubMed ID: 19007310
[TBL] [Abstract][Full Text] [Related]
6. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
[TBL] [Abstract][Full Text] [Related]
8. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
9. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
[TBL] [Abstract][Full Text] [Related]
10. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
[TBL] [Abstract][Full Text] [Related]
11. Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe disease.
Wenger DA
APMIS Suppl; 1993; 40():81-7. PubMed ID: 8311994
[TBL] [Abstract][Full Text] [Related]
12. A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy.
Saravanan K; Büssow H; Weiler N; Gieselmann V; Franken S
J Neurosci Methods; 2007 Apr; 161(2):223-33. PubMed ID: 17204333
[TBL] [Abstract][Full Text] [Related]
13. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.
Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N
Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507
[TBL] [Abstract][Full Text] [Related]
14. The role and metabolism of sulfatide in the nervous system.
Eckhardt M
Mol Neurobiol; 2008; 37(2-3):93-103. PubMed ID: 18465098
[TBL] [Abstract][Full Text] [Related]
15. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
[TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy.
Klein D; Schmandt T; Muth-Köhne E; Perez-Bouza A; Segschneider M; Gieselmann V; Brüstle O
Gene Ther; 2006 Dec; 13(24):1686-95. PubMed ID: 16871228
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
Blomqvist M; Gieselmann V; Månsson JE
Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
[TBL] [Abstract][Full Text] [Related]
18. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructure of sulfatide storage in normal and sulfatase-deficient fibroblasts in vitro.
Rutsaert J; Menu R; Résibois A
Lab Invest; 1973 Nov; 29(5):527-35. PubMed ID: 4356631
[No Abstract] [Full Text] [Related]
20. Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy.
Matzner U; Breiden B; Schwarzmann G; Yaghootfam A; Fluharty AL; Hasilik A; Sandhoff K; Gieselmann V
J Biol Chem; 2009 Apr; 284(14):9372-81. PubMed ID: 19224915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]